Skip to content

Vicor VICR Royalty — Revenue

Similar metrics at other companies

Ultragenyx Pharmaceutical logo
RARERoyalty — Revenue
$47M-2.1%
PTC Therapeutics logo
PTCTRoyalty — Revenue
$46.84M+28.5%
EyePoint, Inc.
 logo
EYPTRoyalty — Revenue
$141K-98.9%
Dianthus Therapeutics logo
DNTHRoyalty — Revenue
$0
Byrna Technologies, Inc. logo
BYRNRoyalty — Revenue
-$282K-135%
Ceva logo
CEVARoyalty — Revenue
$9.2M0.0%

Other financials

Income statement

See full
Revenue$113.0M+20.2%
Gross profit$62.4M+40.6%
Operating income$16.9M+11,432%
Net income$20.7M+714%
EPS (diluted)$0.44+633%

Balance sheet

See full
Cash & equivalents$404.2M+36.5%
Total debt$7.1M+1.7%
Total equity$753.9M+29.9%
Total assets$804.9M+21.0%

Cash flow

See full
Operating cash flow-$3.9M-120%
CapEx$12.4M+172%
Free cash flow-$16.3M-205%

Valuation

See full
Market cap$12.06B+471%
Enterprise value$11.66B+555%
P/E88.2×+56.0×
P/S25.6×+20.6×

Profitability

See full
Gross margin58.8%+9.2pp
Operating margin21%
Net margin29%+22.7pp
FCF margin18.5%+5.6pp

Returns & leverage

See full
Return on equity20.5%+16.3pp
Debt / equity0.0×
Current ratio14.3×+7.9×

Where this comes from

Reported directly by Vicor in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Vicor’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vicor's royalty — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vicor's royalty — revenue?
Vicor (VICR) reported royalty — revenue of $14.97M in Q1 2026.
How has Vicor's royalty — revenue changed year-over-year?
Vicor's royalty — revenue increased by 39.1% year-over-year, from $10.76M to $14.97M.
What is the long-term trend for Vicor's royalty — revenue?
Over 3 years (2022 to 2025), Vicor's royalty — revenue has grown at a 173.6% compound annual growth rate (CAGR), from $2.8M to $57.38M.
What does royalty — revenue mean?
This metric represents the gross revenue recognized from intellectual property licensing agreements and royalty-bearing technology arrangements within the company's royalty segment. It reflects the economic value derived from allowing third parties to utilize proprietary power conversion technologies without the direct manufacturing or sale of physical hardware. This revenue stream is typically driven by the adoption rate of the company's patented innovations in external product ecosystems.